ArticleMicroorganisms2021

A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis.

Vasiliki Pappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.